From the Editor-in-Chief

Increased vaccination rates can help reduce cervical cancer as a worldwide health threat.

by William G. Nelson, MD, PhD

Patients find each other online and get support they say is unparalleled, but with openness comes concern about privacy.

by Kate Yandell

Genetic testing for mutations in the BRCA1 and BRCA2 genes creates opportunities for cancer risk reduction. But 25 years after the mutations were discovered, some who could benefit from testing are still left out.

by Sue Rochman

Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.

by Marci A. Landsmann

Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.

by Marci A. Landsmann

Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.

by Ashley P. Taylor

Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.

by Marci A. Landsmann

A study adds to evidence that many patients with ductal carcinoma in situ do not need to have their lymph nodes removed.

by Cheryl Platzman Weinstock

In a study of women with breast cancer in North Carolina, those who lived in rural areas or were black were more likely than urban white women to report negative changes in their employment.

by Pamela Rafalow Grossman

Cognitive behavioral therapy may help cancer survivors cope with fear of recurrence, some studies say.

by Jon Kelvey